Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
NCT05766553 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-01-13
Summary
Investigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving.
The study hypothesis is that the practice of mindfulness meditation in a virtual reality environment reduces the craving induced by cues and stress and therefore ultimately smoking relapse.
The main objective of the protocol will be to demonstrate that mindfulness meditation can reduce long-term relapse (continuous cessation (\> 30 days) of smoking cessation).
The participants will be randomized into two groups: the experimental group will perform six virtual reality sessions in a multisensory cabin at the rate of one session per week; the control group will be prescribed the gold standard treatment (nicotine patches and chewing gum).
Participants will be seen again at three and six months to assess whether or not there has been a smoking relapse.
Conditions
- Tobacco Use Disorder
Interventions
- OTHER
-
Virtual reality pod
The first two sessions provide guided training in relaxation and mindfulness through immersion in a virtual forest environment for the first session, and in a virtual beach environment for the second. Sessions 3 and 4 present environments with addiction-related stimuli (Cues). The session 3 consists of a walk through the virtual street environment, buying a bottle of water from the store, and then ordering a coffee from a virtual bar. The session 4 takes place in a virtual party environment in an apartment: people smoke and drink alcohol in the living room, the session consists of sitting with them, then going to the kitchen to get a water bottle. Sessions 5 and 6 present stressful environments. Session 5 consists of a virtual parachute jump. The 6th session takes place in a virtual airplane environment, which will encounter turbulence.
- OTHER
-
nicotine patches and chewing gum
Participants in this group will be prescribed a Gold Standard smoking cessation treatment with nicotine patches adapted to their consumption and 4mg nicotine chewing gum for a period of 3 months.
Sponsors & Collaborators
-
Centre Hospitalier Henri Laborit
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-15
- Primary Completion
- 2026-10-15
- Completion
- 2026-12-15
Countries
- France
Study Locations
More Related Trials
-
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
NCT03083353 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes
NCT01414998 ·Status: COMPLETED ·Phase: NA
-
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
NCT02590640 ·Status: COMPLETED ·Phase: NA
-
Transcranial Direct Current Stimulation - Tobacco Use Disorder
NCT03691805 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605 ·Status: COMPLETED ·Phase: NA
-
Provoked Craving Relief Study by NRT
NCT01476202 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varenicline on Reactivity to Smoking and Drinking Cues
NCT00873535 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotine in Tobacco Smokers
NCT03651869 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
NCT00133757 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers
NCT00267813 ·Status: COMPLETED ·Phase: NA
-
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
NCT01406223 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
NCT04135937 ·Status: COMPLETED ·Phase: PHASE4
-
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960 ·Status: COMPLETED ·Phase: NA
-
Nicotine Treatment of Impulsivity in Parkinson's Disease
NCT01216904 ·Status: UNKNOWN ·Phase: PHASE4
-
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
NCT02162849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Innovative Interventions for Smoking Cessation
NCT01050569 ·Status: COMPLETED ·Phase: PHASE2
-
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
NCT00699556 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of tDCS for Vaping Reduction
NCT06885606 ·Status: RECRUITING ·Phase: NA
-
Extinction Based Treatment for Nicotine Dependence
NCT00831155 ·Status: COMPLETED ·Phase: PHASE1
-
Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2
NCT00135746 ·Status: COMPLETED ·Phase: NA
-
Effect of the Electronic Cigarette on Withdrawal Symptoms
NCT01454362 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599 ·Status: RECRUITING ·Phase: NA
-
Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation
NCT00289653 ·Status: COMPLETED ·Phase: NA